Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups

References

• AmBisome (amphotericin B liposome for injection) [package insert]. AstellasDeerfield ILAstellas Pharma US, Inc [revised May 2012]. Available from: http://www.astellas.us/docs/ambisome.pdfAccessed August 6, 2013
   Google Scholar
• Abelcet (amphotericin B lipid complex injection) [package insert]. DailymedBridgewater NJEnzon Pharmaceuticals revised May 2010]. Available from: http://abelcet.com/Accessed August 6, 2013
   Google Scholar
• SalibaFDupontBRenal impairment and amphotericin B formulations in patients with invasive fungal infectionsMed Mycol20084629711218324488
   PubMed Web of Science ®Google Scholar
• WingardJRKubilisPLeeLClinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosisClin Infect Dis19992961402140710585786
   PubMed Web of Science ®Google Scholar
• BassettiMAversaFBalleriniFAmphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patientsClin Drug Investig20113111745758
   Web of Science ®Google Scholar
• HorwitzEShavitOShouvalRHoffmanAShapiroMMosesAEEvaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactionsInt J Clin Pharm201234461161722674178
   PubMed Web of Science ®Google Scholar
• MistroSMacielIMde MenezesRGMaiaZPSchooleyRTBadaroRDoes lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysisClin Infect Dis201254121774177722491505
   PubMed Web of Science ®Google Scholar
• SunHYAlexanderBDLortholaryOLipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisClin Infect Dis200949111721172819886800
   PubMed Web of Science ®Google Scholar
• HamillRJSobelJDEl SadrWComparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safetyClin Infect Dis201051222523220536366
   PubMed Web of Science ®Google Scholar
• ChuPSadullahSThe current role of amphotericin B lipid complex in managing systemic fungal infectionsCurr Med Res Opin200925123011302019849324
   PubMed Web of Science ®Google Scholar
• RexJHWalshTJEstimating the true cost of amphotericin BClin Infect Dis19992961408141010585787
   PubMed Web of Science ®Google Scholar
• Alvarez-LermaFMariscalFQuintanaEImpact of the administration of liposomal amphotericin B in patients with renal function impairment at initiation of treatmentJ Chemother201022428528720685637
   PubMed Web of Science ®Google Scholar
• VincentJLde MendoncaACantraineFUse of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care MedicineCrit Care Med19982611179318009824069
   PubMed Web of Science ®Google Scholar
• Rabe-HaskethSSkrondalAMultilevel and Longitudinal Modeling using STATACollege Station, TXStata Press, StataCorp LP2008
   Google Scholar
• AustinPCTuJVBootstrap methods for developing predictive modelsAm Stat2004582131137
   Web of Science ®Google Scholar
• RafteryABayesian model selection in social researchSociol Res199525111163
   Google Scholar
• GuoSFraserMWPropensity Score Analysis: Statistical Methods and ApplicationsThousand OaksSAGE Publications2010
   Google Scholar
• Laniado-LaborinRCabrales-VargasMNAmphotericin B: side effects and toxicityRev Iberoam Micol200926422322719836985
   PubMed Web of Science ®Google Scholar
• PerfectJRDismukesWEDromerFClinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of AmericaClin Infect Dis201050329132220047480
   PubMed Web of Science ®Google Scholar
• PappasPGKauffmanCAAndesDClinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of AmericaClin Infect Dis200948550353519191635
   PubMed Web of Science ®Google Scholar
• WalshTJFinbergRWArndtCLiposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study GroupN Engl J Med19993401076477110072411
   PubMed Web of Science ®Google Scholar
• SharkeyPKGraybillJRJohnsonESAmphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSClin Infect Dis19962223153218838189
   PubMed Web of Science ®Google Scholar
• WhiteMHBowdenRASandlerESRandomized, double-blind clinical trial of amphotericin B colloidal dispersion vs amphotericin B in the empirical treatment of fever and neutropeniaClin Infect Dis19982722963029709879
   PubMed Web of Science ®Google Scholar
• BowdenRChandrasekarPWhiteMHA double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patientsClin Infect Dis200235435936612145716
   PubMed Web of Science ®Google Scholar
• DerayGAmphotericin B nephrotoxicityJ Antimicrob Chemother200249Suppl 1374111801579
   PubMed Web of Science ®Google Scholar
• FisherMATalbotGHMaislinGMcKeonBPTynanKPStromBLRisk factors for Amphotericin B-associated nephrotoxicityAm J Med19898755475522816970
   PubMed Web of Science ®Google Scholar
• BatesDWSuLYuDTCorrelates of acute renal failure in patients receiving parenteral amphotericin BKidney Int20016041452145911576359
   PubMed Web of Science ®Google Scholar
• MeunierFPrenticeHGRingdenOLiposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trialJ Antimicrob Chemother199128Suppl B83911778895
   PubMed Web of Science ®Google Scholar
• WingardJRWhiteMHAnaissieERaffalliJGoodmanJArrietaAA randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study GroupClin Infect Dis20003151155116311073745
   PubMed Web of Science ®Google Scholar
• LuberADMaaLLamMGuglielmoBJRisk factors for amphotericin B-induced nephrotoxicityJ Antimicrob Chemother199943226727111252333
   PubMed Web of Science ®Google Scholar